NCT00717613

Brief Summary

This study includes an interview with men who have selected "watchful waiting" or "active surveillance" for their localized prostate cancer, in lieu of active treatment (such as surgery or radiation). We hope to understand the educational and support needs of men on surveillance so that we can develop a new intervention that will improve quality of life for such men.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jul 2007

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2007

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

July 16, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 17, 2008

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2009

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2011

Completed
Last Updated

January 23, 2018

Status Verified

January 1, 2018

Enrollment Period

2.3 years

First QC Date

July 16, 2008

Last Update Submit

January 18, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Health-related quality of life, particularly cancer-specific anxiety and general anxiety

    One time retrospective interview

Study Arms (1)

1

Observational cohort study

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Convenience sample of men on active surveillance drawn from large academic medical centers, community hospitals, support groups, and the internet.

You may qualify if:

  • \) male,
  • \) 18 years or older, with biopsy-proven prostate cancer,
  • \) diagnosed with localized disease within the last 24 months,
  • \) have a telephone at the time of enrollment,
  • \) have an address where they can receive study materials by mail (a street address or post office box),
  • \) able to speak and understand English;
  • \) have selected surveillance, rather than active treatment for his prostate cancer.

You may not qualify if:

  • \) female
  • \) no diagnosis of localized prostate cancer
  • \) completed or undergoing active treatment (e.g., surgery, radiotherapy, etc.)
  • \) no phone or US mail address
  • \) unwilling or unable to provide informed consent
  • \) unable to speak and understand English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Baylor College of Medicine

Houston, Texas, 77030, United States

Location

Study Officials

  • David M Latini, PhD

    Baylor College of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Adjunct Assistant Professor of Urology

Study Record Dates

First Submitted

July 16, 2008

First Posted

July 17, 2008

Study Start

July 1, 2007

Primary Completion

October 1, 2009

Study Completion

October 1, 2011

Last Updated

January 23, 2018

Record last verified: 2018-01

Locations